KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Arginine Dentifrices and Childhood Caries Prevention: A Randomized Clinical Trial.

W Yin, Z Zhou, R-Z Huang, G Sun, Y Zhong, Z Yang, Y Li, Y Zhang, P Zhang, D Hu, L R Mateo, G Gao, S Lim, A I Ismail, J Zimmerman, B Garcia-Godoy, M Ryan, Y-P Zhang

JDR Clin Trans Res 11(2) 204-214

PMID40794532
PMCIDPMC12967385
DOI10.1177/23800844251361471
发表日期2025-08-12
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 2 张 PMC Figure,均未识别为 KM 图:Figure 1.:CONSORT/入组流程图;Figure 2.:图注未提示 KM 曲线。
摘要

摘要

BACKGROUND: Dental caries remains a significant oral health burden globally. Scientific evidence has demonstrated the dose-dependent anticaries action of fluoride; however, more effective, comprehensive, and alternative prevention strategies are required. METHODS: A 2-y, phase 3, randomized controlled trial based on a double-blind, 3-arm, parallel-group design was conducted from April 15, 2019, through March 12, 2022 across 3 centers in China. Six thousand children aged 10 to 14 y with ≥2 active caries lesions were assigned 1 of 3 study dentifrices: 8.0% arginine, 1.5% arginine, and 0.32% sodium fluoride (NaF). The primary efficacy outcomes were incremental DMFS (decayed, missing, and filled surfaces) and DMFT (decayed, missing, and filled teeth) caries indices scores after 2 y of product use. The secondary efficacy outcomes were the incremental caries indices scores after 1 y and 6 mo of product use. Noninferiority was achieved if the 95% CI of the mean difference in scores was below the noninferiority margin of 0.2545 after 2 y, 1 y, and 6 mo of product use. RESULTS: After 2 y, the 8.0% arginine-containing dentifrice demonstrated a statistically significant reduction of 26.0% in DMFS scores (-0.16; 95% CI, -0.22 to -0.10; P < .001) and 25.3% in DMFT scores (-0.17; 95% CI, -0.24 to -0.11; P < .001) versus control. No statistical difference was measured between the 1.5% arginine-containing dentifrice and control in DMFS (-0.01; 95% CI, -0.07 to 0.05; P = .819) and DMFT (-0.01; 95% CI, -0.07 to 0.05; P = .739). CONCLUSIONS: Dentifrice containing 8.0% arginine showed a statistically significant reduction in caries incidence versus the NaF control, while the 1.5% arginine dentifrice showed equivalence to the NaF control regarding caries reduction. This clinical study confirms that arginine dentifrices are effective alternatives to fluoride in providing anticaries protection.Knowledge Transfer Statement:This study demonstrates that arginine is an efficacious anticaries agent at the examined doses of 1.5% and 8%. Clinicians and consumers can consider this a new caries preventive agent providing choice to people seeking fluoride-free alternatives. Policy makers could leverage these findings to guide oral health initiatives and inform regulations on dentifrice composition, promoting broader access to effective caries prevention methods.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(2,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure 1.CONSORT diagram. The CONSORT flow diagram shows the number of participants assessed for eligibility; randomized; and allocated to the study products, follow-up, and analysis. ITT, intention to treat; NaF, sodium fluoride; TP, toothpaste.
非 KM Figure
Figure 2.Noninferiority assessment of incremental DMFS and DMFT caries at the 2-y evaluation of 8.0% and 1.5% arginine dentifrice vs. 0.32% NaF dentifrice. DMFS caries index: ( A ) 8.0% arginine vs. 0.32% NaF dentifrice; ( B ) 1.5% arginine vs. 0.32% NaF dentifrice. DMFT caries index: ( C ) 8.0% arginine vs. 0.32% NaF dentifrice; ( D ) 1.5% arginine vs. 0.32% NaF dentifrice. DMFS, decayed, missing, and filled surfaces; DMFT, decayed, missing, and filled teeth.
非 KM Figure